MA26949A1 - Procede pour la preparation d'acides n-arylanthraniliques et de leurs derives. - Google Patents

Procede pour la preparation d'acides n-arylanthraniliques et de leurs derives.

Info

Publication number
MA26949A1
MA26949A1 MA27069A MA27069A MA26949A1 MA 26949 A1 MA26949 A1 MA 26949A1 MA 27069 A MA27069 A MA 27069A MA 27069 A MA27069 A MA 27069A MA 26949 A1 MA26949 A1 MA 26949A1
Authority
MA
Morocco
Prior art keywords
preparation
derivatives
arylanthranilic
arylanthranilic acids
acids
Prior art date
Application number
MA27069A
Other languages
English (en)
Inventor
Michael Huai Gu Chen
Edward Mark Davis
Javier Magano
Thomas Norman Nanninga
Derick Dale Winkle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of MA26949A1 publication Critical patent/MA26949A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

DEPOSANT Société dite : WARNER-LAMBERT COMPANY LLC REVENDICATION DE PRIORITES US 25 Août 2000 60/228,206 Voir en annexe le titre de l'invention et le texte de l'abrégé Procédé pour la préparation d'acides N-arylanthraniliques et de leurs dérivés La présente invention concerne un procédé pour la préparation d'acides N-arylanthraniliques et un procédé pour la préparation d'esters, amides et esters hydroxamiques N-arylanthraniliques.
MA27069A 2000-08-25 2003-03-14 Procede pour la preparation d'acides n-arylanthraniliques et de leurs derives. MA26949A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25

Publications (1)

Publication Number Publication Date
MA26949A1 true MA26949A1 (fr) 2004-12-20

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27069A MA26949A1 (fr) 2000-08-25 2003-03-14 Procede pour la preparation d'acides n-arylanthraniliques et de leurs derives.

Country Status (32)

Country Link
EP (1) EP1313694A1 (fr)
JP (1) JP2004507518A (fr)
KR (1) KR20030059115A (fr)
CN (1) CN1458921A (fr)
AP (1) AP2001002249A0 (fr)
AR (1) AR032175A1 (fr)
AU (1) AU2001277044A1 (fr)
BG (1) BG107635A (fr)
BR (1) BR0113520A (fr)
CA (1) CA2420003A1 (fr)
CZ (1) CZ2003477A3 (fr)
DO (1) DOP2001000238A (fr)
EA (1) EA200300187A1 (fr)
GT (1) GT200100174A (fr)
HN (1) HN2001000216A (fr)
HU (1) HUP0300828A2 (fr)
IL (1) IL154507A0 (fr)
IS (1) IS6724A (fr)
MA (1) MA26949A1 (fr)
MX (1) MXPA03001654A (fr)
NO (1) NO20030844L (fr)
PA (1) PA8526501A1 (fr)
PE (1) PE20020393A1 (fr)
PL (1) PL360699A1 (fr)
PY (1) PY0120841A (fr)
SK (1) SK2072003A3 (fr)
SV (1) SV2002000601A (fr)
TN (1) TNSN01127A1 (fr)
UY (1) UY26908A1 (fr)
WO (1) WO2002018319A1 (fr)
YU (1) YU14303A (fr)
ZA (1) ZA200301182B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100984595B1 (ko) 2002-03-13 2010-09-30 어레이 바이오파마 인크. Ｍｅｋ 억제제로서의 ｎ3 알킬화 벤즈이미다졸 유도체
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
NZ546011A (en) 2003-10-21 2009-09-25 Warner Lambert Co Polymorphic form of N-[(R)-2,3-dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
CN1905873A (zh) 2003-11-19 2007-01-31 阵列生物制药公司 Mek的杂环抑制剂及其使用方法
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
NZ590160A (en) 2003-11-21 2012-07-27 Array Biopharma Inc AKT protein kinase inhibitors
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
JP5154406B2 (ja) 2005-04-13 2013-02-27 アステックス、セラピューティックス、リミテッド 医薬化合物
ES2405785T3 (es) 2005-05-18 2013-06-03 Array Biopharma Inc. Inhibidores heterocíclicos de MEK y métodos de uso de los mismos
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
ATE523499T1 (de) 2006-07-06 2011-09-15 Array Biopharma Inc Cyclopenta [d]-pyrimidine als akt-proteinkinasehemmer
ATE532789T1 (de) 2006-07-06 2011-11-15 Array Biopharma Inc Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
CA2656566C (fr) 2006-07-06 2014-06-17 Array Biopharma Inc. Dihydrofuro pyrimidines comme inhibiteurs de la proteine kinase akt
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2073802A1 (fr) 2006-10-12 2009-07-01 Astex Therapeutics Limited Combinaisons pharmaceutiques
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
WO2008044041A1 (fr) 2006-10-12 2008-04-17 Astex Therapeutics Limited Combinaisons pharmaceutiques
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
EP2073807A1 (fr) 2006-10-12 2009-07-01 Astex Therapeutics Limited Combinaisons pharmaceutiques
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
WO2009006567A2 (fr) 2007-07-05 2009-01-08 Array Biopharma Inc. Cyclopentanes de pyrimidyle comme inhibiteurs de protéines kinases akt
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CN101918373B (zh) 2007-07-05 2013-06-05 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
ES2422733T3 (es) 2008-01-09 2013-09-13 Array Biopharma Inc Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
EP2240455B1 (fr) 2008-01-09 2012-12-26 Array Biopharma, Inc. Pyrimidyl cyclopentane hydroxylé en tant qu'inhibiteur de protéine kinase akt
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
JP2013519714A (ja) * 2010-02-19 2013-05-30 センター ナショナル デ ラ リシェルシェ サイエンティフィック 芳香族求核置換によって目的の化学化合物を調製するための方法
CN102985399A (zh) * 2010-02-19 2013-03-20 国家科学研究中心 通过对携带至少一个吸电子基团的芳香族羧酸衍生物进行亲核芳香族取代来制备目的化合物的方法
WO2012135781A1 (fr) 2011-04-01 2012-10-04 Genentech, Inc. Combinaisons de composés inhibiteurs d'akt et d'agents chimiothérapeutiques, et procédés d'utilisation
RU2013148817A (ru) 2011-04-01 2015-05-10 Дженентек, Инк. Комбинации соединений-ингибиторов акт и мек и способы их применения
KR102204520B1 (ko) * 2012-10-12 2021-01-20 엑셀리시스, 인코포레이티드 암의 치료에 사용하기 위한 화합물의 신규 제조 방법
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用
CN119948008B (zh) * 2022-07-15 2026-04-28 南方科技大学 一种以异腈和环丙烯为原料制备稠环芳胺的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
AU5610398A (en) * 1997-02-28 1998-09-18 Warner-Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
NZ501276A (en) * 1997-07-01 2000-10-27 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders
BR9810385A (pt) * 1997-07-01 2000-09-05 Warner Lambert Co Derivados de ácido benzóico 2-(4-bromo ou 4-iodo fenilamino) e sua utilização como inibidores de mek
CA2348236A1 (fr) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, et 4-arylthio diarylamines et leurs derives comme inhibiteurs selectifs de mek
PT1171418E (pt) * 1999-04-21 2005-02-28 Warner Lambert Co Metodo de preparacao de acidos 2-(n-fenilamino)benzoicos

Also Published As

Publication number Publication date
JP2004507518A (ja) 2004-03-11
YU14303A (sh) 2006-08-17
BG107635A (bg) 2004-09-30
NO20030844D0 (no) 2003-02-24
PA8526501A1 (es) 2002-07-30
BR0113520A (pt) 2003-06-24
TNSN01127A1 (en) 2005-11-10
HUP0300828A2 (hu) 2003-09-29
WO2002018319A1 (fr) 2002-03-07
HN2001000216A (es) 2002-05-22
PL360699A1 (en) 2004-09-20
PY0120841A (es) 2004-06-01
CN1458921A (zh) 2003-11-26
KR20030059115A (ko) 2003-07-07
ZA200301182B (en) 2004-05-12
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (cs) 2003-10-15
SK2072003A3 (en) 2004-01-08
EP1313694A1 (fr) 2003-05-28
GT200100174A (es) 2002-07-18
DOP2001000238A (es) 2003-01-31
PE20020393A1 (es) 2002-05-09
SV2002000601A (es) 2002-04-03
MXPA03001654A (es) 2004-09-10
AP2001002249A0 (en) 2001-09-30
AR032175A1 (es) 2003-10-29
IS6724A (is) 2003-02-20
NO20030844L (no) 2003-02-25
CA2420003A1 (fr) 2002-03-07
EA200300187A1 (ru) 2003-08-28
IL154507A0 (en) 2003-09-17
UY26908A1 (es) 2001-11-30

Similar Documents

Publication Publication Date Title
MA26949A1 (fr) Procede pour la preparation d'acides n-arylanthraniliques et de leurs derives.
BR9904998A (pt) Derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
GR3036305T3 (en) Chiral methyl phenyl oxazolidinones
MY151458A (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
MA27182A1 (fr) Derives de thiazole et d'oxazole qui modulent l'activite de ppar.
FR2814174B1 (fr) Lubrifiants contenant des esters d'acides gras substitues par un groupe 5-tert-butyl-4-hydroxy-3-methylphenyle
EP1219596A4 (fr) Derives de salicylamide
SI1274685T1 (sl) Derivat piridin-1-oksida in postopek njegove transformacije v farmacevtsko ucinkovite sestavine
MXPA02012889A (es) Esteres de acidos 4-alcoxi-ciclohexano-1-amino-carboxilicos y procedimiento para su obtencion.
EP1352965A4 (fr) Procede de preparation d'un compose d'amide au moyen d'un catalyseur microbien
MA27169A1 (fr) Metabolites de l'acide (3-{ [(4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetique
GB2383041B (en) Process for the preparation of gabapentin
DZ3041A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procédé pour sa préparation.
HUP9901260A3 (en) Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate
DZ2607A1 (fr) Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs.
YU15002A (sh) Upotreba alfa-lipoinske kiseline ili njenih derivata
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
MXPA02012112A (es) Composiciones que contienen policarbonato.
ITTO20010028A0 (it) Metodo per aumentare l'attivita' antitumorale di una sostanza contenente amigdalina, composizione contenente una sostanza con contenuto aume
BR0016400A (pt) Processo para a preparação de sais de sódio de estatinas
WO2001054647A3 (fr) Composition pharmaceutique comprenant des transporteurs de produits a base de vitamine e, de papaine et d'hyaluronidase
DZ2932A1 (fr) Dérivés d'hygromycine a nouveaux, procédé pour le ur préparation et compositions pharmaceutiques lescontenant.
DE69629703D1 (de) Synthese von optisch reinen verbindungen als garft-inhibitoren und deren zwischenprodukte